QualityStocksNewsBreaks Archives - Page 432 of 1533

WednesdayJan 18, 2023 11:20 am

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc.’s (CIPI) VP of Sales Discusses Disruptive Mindset to Drive Solutions in New Interview

Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean energy solutions provider for all of North America, has published a new interview with its Vice President of Sales Jim Fiorentino. During the interview, Fiorentino discussed his introduction to the clean tech space and Correlate, as well as the team’s focus to implement advanced technologies. “Firstly, we’re building long term sustainability planning and driving NOI for our customers at every phase. Secondly, watching the market respond positively to our tech-enabled development work, in a remote environment that removes high engineering expenses. It has validated our methodology of using data…

WednesdayJan 18, 2023 10:34 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Promising Results from Kernel Flow(R) Feasibility Study

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced key highlights from the completed feasibility study conducted by its partner HI, LLC dba Kernel (“Kernel”). The study was designed to evaluate Kernel’s Flow(R) wearable technology to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics. “The results from the feasibility study are very promising and provide further insights into the potential of this cutting-edge wearable technology to quantify neural activity and changes in brain biomarkers during the administration of psychedelics. The possibility of using this technology to develop a predictive tool to aid…

WednesdayJan 18, 2023 10:13 am

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Q3 2023 Financial Results

FingerMotion (NASDAQ: FNGR), a mobile services and data company, has announced its financial results for the third quarter ended Nov. 30, 2022. Among the highlights, the company reported record quarterly revenue of $11.40 million and a quarterly increase in revenues of 93% compared to Q3 2022. “The Chinese ‘lockdowns’ are over now, but during the quarter they still had an impact on the company's revenue mix,” said Martin Shen, CEO of FingerMotion. “The company managed the quarter by focusing available resources to the top-up business as our corporate SMS customers were not interested in driving traffic to retail establishments that…

TuesdayJan 17, 2023 12:49 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) to Participate in Amvest Capital Investor Webinar

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, will be presenting an investor webinar. The webinar, hosted by Amvest Capital, is scheduled for Feb. 14, 2023. According to the announcement, the webinar will include an operational overview, updates on technology and product development efforts and commercialization activities; the presentation will also include strategic investor and public relations efforts. Webinar participants will include Hillcrest executives, including CEO Don Currie, chief technology officer Ari Berger, chief commercialization officer James Bolen, and Systematec GmbH managing director, owner and founder…

TuesdayJan 17, 2023 11:57 am

QualityStocksNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Updates Status on Proposed NASDAQ Uplisting

Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” is releasing an update regarding its proposed uplist to the Nasdaq Capital Market. According to the announcement, based on the company’s annual report filing on Form 10-K for FY 2022, ATDS will no longer be subject to NASDAQ’s higher seasoning threshold for price compliance; the company believes this will “hasten” its uplisting to NASDAQ. “We are excited to file our 2022 Form 10-K and, as a seasoned issuer, no longer be subject to Nasdaq’s 30-of-60-day price requirement,” said Data443 Risk Mitigation CEO and…

TuesdayJan 17, 2023 11:49 am

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Among First of Nasdaq Companies to Dual List on Upstream

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, last week became the second NASDAQ company to dual list on Upstream under the ticker symbol JUPW. Jupiter Wellness released a digital collectible NFT to commemorate the dual listing, which is available for all Upstream participants to claim with the code “JUPW.” “We are thrilled to be among the first companies to dual list on Upstream’s next generation marketplace,” said Jupiter Wellness CEO Brian John. “We are adding new value to our shareholders while expanding our company and mission to a modern, global investor-base.” To view the…

TuesdayJan 17, 2023 11:10 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Provides Strategic Update in Annual Shareholder Letter

Lexaria Bioscience (NASDAQ: LEXX) CEO Chris Bunka has released an annual letter to shareholders. The detailed letter talks about company highlights throughout the year, including the fact that, despite challenges such as global supply chain disruptions and threatening inflation, “Lexaria continues to navigate well and is focused on those things it can control such as applied R&D designed to entice others to work with us commercially. . . . [The company] has not terminated any staff and in fact our in-house team as well as our external consultant head-count has never been higher, in order to conduct and [analyze] an…

FridayJan 13, 2023 3:45 pm

QualityStocksNewsBreaks – REZYFi Inc. Positioning to Operate Competitively in Challenging Lending Markets

REZYFi, a specialized financing company and a growing mortgage lender, is working to help businesses navigate the challenging landscape of loan origination, particularly as it applies to the traditionally underserved cannabis industry and property owners who lease to such companies. “REZYFi is anticipating the launch of its high-margin cannabis division in the coming weeks to focus on such challenging lending markets. The company is developing a proprietary technology that will help it operate competitively by maintaining efficient turnaround time while also being economical with staffing levels,” a recent article reads. “Through its subsidiaries, REZYFi Lending and ResMac Inc., the company…

FridayJan 13, 2023 3:19 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) Enabling SMBs to Build Highly Effective Cybersecurity and Privacy Programs

SideChannel (OTCQB: SDCH) is guided by the belief that small and mid-sized businesses (“SMBs”) deserve the expertise of an experienced chief information security officer (“CISO”) just as much as a larger enterprise but at a more reasonable cost. “The company is helping organizations all over the world improve their cybersecurity and move their mission forward. SideChannel matches companies with an expert virtual CISO (‘vCISO’), so companies can assess cyber risk and ensure cybersecurity compliance – all without jeopardizing financial assets,” a recent article explains. “SideChannel sees its role as to make it as easy as possible for small and mid-sized…

FridayJan 13, 2023 12:57 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb Pipeline Targeting Large Underserved Medical Needs

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently announced statistically significant (p<0.001) efficacy results in a preclinical in-vivo proof-of-concept study of its innovative inhaled nanosized antibody (“NanoAb”) COVID-19 therapy. “The study concluded that compared to pre-infection weight, the control group’s weight declined on average at 12.01%. In contrast, on average, the weight of the experimental group using BiondVax’s NanoAb therapy declined only 3.80%. The successful result of the study was further supported by eight other tracked parameters, including heart rate and social behaviors,…

Site Search

Company Search

Category: QualityStocksNewsBreaks